Prolonged survival of allogeneic islet grafts in NOD mice treated with a combination of anti-CD45RB and anti-CD154 antibodies

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 248-249

  Molano, R D ^a   Berney, T ^a   Pileggi, A ^a   Ricordi, C ^a   Burkly, L ^b   Rothstein, D ^c   Basadonna, G ^c   Inverardi, L ^a,d  

^a UNIVERSITY OF MIAMI   (United States)

^b BIOGEN   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD45RB; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; GRAFT REJECTION; GRAFT SURVIVAL; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD45; CD40 LIGAND; GRAFT SURVIVAL; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035082145     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01998-9     Document Type: Conference Paper

References (6)